BLAUWBLOMME: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
What changed
BLAUWBLOMME
NACE 47.730, Retail sale of pharmaceutical products
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
-€31,727
2024 · -€50,956+€19,228
Equity
-€279,784
2024 · -€248,056-€31,727
Cash
€42,802
2024 · €43,382-€580
Balance sheet total
€611,690
2024 · €649,341-€37,651
Largest movements
Assets
- Tangible fixed assets -€43,107
down €43,107 (-13.9%), from €309,595 to €266,488
of which Land and buildings: -€21,965
- Receivables within one year +€8,424
up €8,424 (+9.0%), from €93,495 to €101,919
of which Trade receivables: +€10,753
Equity and liabilities
- Debts after one year -€39,733
down €39,733 (-87.0%), from €45,658 to €5,925
- Other debts +€37,439
up €37,439 (+6.3%), from €592,820 to €630,259
- Short-term financial debts +€34,760
up €34,760 (+55.6%), from €62,483 to €97,243
- Current portion of long-term debt -€34,711
down €34,711 (-43.1%), from €80,461 to €45,749
- Profit (loss) carried forward -€31,727
down €31,727 (-11.7%), from -€270,764 to -€302,491
Income statement
- Staff costs -€32,761
down €32,761 (-21.6%), from €151,548 to €118,787
- Gross operating margin -€16,319
down €16,319 (-9.5%), from €171,075 to €154,756
- Financial income +€2,414
up €2,414 (+175%), from €1,378 to €3,792
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Result 2024
-€50,956
Gross operating margin
-€16,319
Staff costs
+€32,761
Depreciation
+€777
Other operating charges
+€415
Other operating items
+€201
Financial income
+€2,414
Financial charges
-€1,021
Result 2025
-€31,727
raises the resultlowers the resultnot broken down further in the accounts
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
From operations
+€40,253
Investment
-€1,150
Financing
-€39,683
Cash 2024
€43,382
From operations (derived)
+€40,253
Net result for the year
-€31,727
Depreciation
+€44,257
Stocks and contracts
+€2,795
Receivables within one year
-€8,424
Deferred charges and accrued income
-€407
Trade debts
-€9,411
Tax, wage and social debts
+€6,046
Advances received
-€16
Other debts
+€37,439
Accrued charges and deferred income
-€298
Investment (derived)
-€1,150
Investment in fixed assets (net)
-€1,150
Financing
-€39,683
Debts after one year
-€39,733
Current portion of long-term debt
-€34,711
Short-term financial debts
+€34,760
Cash 2025
€42,802
brings cash intakes cash out
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €649,341 | €611,690 | -€37,651 | -5.8% |
| Fixed assets | 21/28 | €314,595 | €271,488 | -€43,107 | -13.7% |
| Tangible fixed assets | 22/27 | €309,595 | €266,488 | -€43,107 | -13.9% |
| Land and buildings | 22 | €166,696 | €144,730 | -€21,965 | -13.2% |
| Plant, machinery and equipment | 23 | €79,778 | €68,484 | -€11,294 | -14.2% |
| Furniture and vehicles | 24 | €1,468 | €1,752 | +€284 | +19.4% |
| Leasing and similar rights | 25 | €7,314 | €4,876 | -€2,438 | -33.3% |
| Other tangible fixed assets | 26 | €54,340 | €46,646 | -€7,694 | -14.2% |
| Financial fixed assets | 28 | €5,000 | €5,000 | = | 0.0% |
| Current assets | 29/58 | €334,746 | €340,202 | +€5,456 | +1.6% |
| Stocks and contracts in progress | 3 | €196,706 | €193,912 | -€2,795 | -1.4% |
| Stocks | 30/36 | €196,706 | €193,912 | -€2,795 | -1.4% |
| Amounts receivable within one year | 40/41 | €93,495 | €101,919 | +€8,424 | +9.0% |
| Trade receivables | 40 | €87,427 | €98,180 | +€10,753 | +12.3% |
| Other amounts receivable | 41 | €6,068 | €3,739 | -€2,329 | -38.4% |
| Cash at bank and in hand | 54/58 | €43,382 | €42,802 | -€580 | -1.3% |
| Deferred charges and accrued income | 490/1 | €1,163 | €1,569 | +€407 | +35.0% |
| Total equity and liabilities | 10/49 | €649,341 | €611,690 | -€37,651 | -5.8% |
| Equity | 10/15 | -€248,056 | -€279,784 | -€31,727 | -12.8% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Reserves | 13 | €4,107 | €4,107 | = | 0.0% |
| Non-distributable reserves | 130/1 | €0 | - | = | |
| Reserves not available under the articles | 1311 | €0 | - | = | |
| Distributable reserves | 133 | €4,107 | €4,107 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€270,764 | -€302,491 | -€31,727 | -11.7% |
| Amounts payable | 17/49 | €897,398 | €891,474 | -€5,924 | -0.7% |
| Amounts payable after more than one year | 17 | €45,658 | €5,925 | -€39,733 | -87.0% |
| Financial debts | 170/4 | €45,658 | €5,925 | -€39,733 | -87.0% |
| Amounts payable within one year | 42/48 | €849,209 | €883,316 | +€34,106 | +4.0% |
| Current portion of amounts payable after more than one year | 42 | €80,461 | €45,749 | -€34,711 | -43.1% |
| Financial debts | 43 | €62,483 | €97,243 | +€34,760 | +55.6% |
| Credit institutions | 430/8 | €62,483 | €97,243 | +€34,760 | +55.6% |
| Trade debts | 44 | €108,049 | €98,638 | -€9,411 | -8.7% |
| Suppliers | 440/4 | €108,049 | €98,638 | -€9,411 | -8.7% |
| Advances received on contracts in progress | 46 | €16 | €0 | -€16 | -100% |
| Taxes, remuneration and social security | 45 | €5,380 | €11,426 | +€6,046 | +112% |
| Taxes | 450/3 | €81 | €1,322 | +€1,241 | +1,532% |
| Remuneration and social security | 454/9 | €5,299 | €10,104 | +€4,805 | +90.7% |
| Other amounts payable | 47/48 | €592,820 | €630,259 | +€37,439 | +6.3% |
| Accrued charges and deferred income | 492/3 | €2,531 | €2,233 | -€298 | -11.8% |
| Remuneration, social security and pensions | 62 | €151,548 | €118,787 | -€32,761 | -21.6% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €45,034 | €44,257 | -€777 | -1.7% |
| Other operating charges | 640/8 | €3,962 | €3,547 | -€415 | -10.5% |
| Non-recurring operating charges | 66A | €201 | €0 | -€201 | -100% |
| Gross operating margin | 9900 | €171,075 | €154,756 | -€16,319 | -9.5% |
| Operating profit (loss) | 9901 | -€29,670 | -€11,835 | +€17,835 | +60.1% |
| Financial income | 75/76B | €1,378 | €3,792 | +€2,414 | +175% |
| Recurring financial income | 75 | €1,378 | €3,792 | +€2,414 | +175% |
| Financial charges | 65/66B | €22,664 | €23,684 | +€1,021 | +4.5% |
| Recurring financial charges | 65 | €22,664 | €23,684 | +€1,021 | +4.5% |
| Profit (loss) for the period before taxes | 9903 | -€50,956 | -€31,727 | +€19,228 | +37.7% |
| Profit (loss) for the period | 9904 | -€50,956 | -€31,727 | +€19,228 | +37.7% |
| Profit (loss) for the period to be appropriated | 9905 | -€50,956 | -€31,727 | +€19,228 | +37.7% |
Source: filed annual accounts (NBB), financial years ended 31 March 2024 and 31 March 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 21 October 2026 via checked.be.